Vivek Garipalli serves as Executive at CLOVER HEALTH INVESTMENTS, CORP. /DE, where they oversee executive responsibilities. Since joining the company, Vivek Garipalli has executed 10 insider transactions totaling $3.0M, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 8, 2025 involved purchasing 31,980 shares valued at $69.4K.
Vivek Garipalli currently holds 1,856,247 shares of CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Vivek Garipalli has been a net buyer of CLOV stock. They have purchased $3.0M and sold $0 worth of shares.
Vivek Garipalli's most recent insider trade was on Aug 8, 2025, when they purchased 31,980 shares at $2.17 per share.
Get notified when new Form 4 filings are submitted
| $2.24 |
| Discretionary |
| Aug 9, 2024 | CLOV | $999.6K | Purchase | 531,700 | $1.88 | Discretionary |
| Jun 17, 2024 | CLOV | $1.0M | Purchase | 877,567 | $1.14 | Discretionary |
| Jan 7, 2024 | CLOV | $0 | Option Exercise | 1,561,065 | $N/A | Discretionary |
| Jan 7, 2024 | CLOV | $1.5M | Payment | 1,561,065 | $0.95 | Discretionary |
| Jan 7, 2023 | CLOV | $0 | Option Exercise | 1,569,594 | $N/A | Discretionary |
| Jan 7, 2023 | CLOV | $1.6M | Payment | 1,569,594 | $1.01 | Discretionary |
| Jan 7, 2022 | CLOV | $0 | Option Exercise | 3,342,698 | $N/A | Discretionary |
| Jan 7, 2022 | CLOV | $5.3M | Payment | 1,664,825 | $3.16 | Discretionary |